Cargando…

Role of CD147 in the development and diagnosis of hepatocellular carcinoma

Hepatocellular carcinoma (HCC) is the most common primary liver cancer, and the third leading cause of cancer-related deaths worldwide. HCC is characterized by insidious onset, and most patients are diagnosed at an advanced stage with a poor prognosis. Identification of biomarkers for HCC onset and...

Descripción completa

Detalles Bibliográficos
Autores principales:	Huang, Defa, Rao, Dingyu, Jin, Qing, Lai, Mi, Zhang, Jiali, Lai, Zhonghong, Shen, Haibin, Zhong, Tianyu
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2023
Materias:	Immunology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10115957/ https://www.ncbi.nlm.nih.gov/pubmed/37090718 http://dx.doi.org/10.3389/fimmu.2023.1149931

Ejemplares similares

Role of exosomes in the development, diagnosis, prognosis and treatment of hepatocellular carcinoma
por: Liu, Meijin, et al.
Publicado: (2023)

Tissue-derived exosome proteomics identifies promising diagnostic biomarkers for esophageal cancer
por: Rao, Dingyu, et al.
Publicado: (2023)

Application of extracellular vesicles proteins in cancer diagnosis
por: Huang, Defa, et al.
Publicado: (2022)

CD147/Basigin: a Warburg oncogene in hepatocellular carcinoma?
por: Calvisi, Diego Francesco
Publicado: (2016)

Differential CD147 Functional Epitopes on Distinct Leukocyte Subsets
por: Pata, Supansa, et al.
Publicado: (2021)

CD147 Expressed on Memory CD4(+) T Cells Limits Th17 Responses in Patients With Rheumatoid Arthritis
por: Miao, Jinlin, et al.
Publicado: (2020)

Efficacy of anti-CD147 chimeric antigen receptors targeting hepatocellular carcinoma
por: Tseng, Hsiang-chi, et al.
Publicado: (2020)

TMEM147 is a novel biomarker for diagnosis and prognosis of hepatocellular carcinoma
por: Fan, Wen-Jie, et al.
Publicado: (2023)

Making cancer fat: reprogramming of lipid metabolism by CD147 in hepatocellular carcinoma
por: Ju, Hye-Lim, et al.
Publicado: (2016)

CD147 promotes collective invasion through cathepsin B in hepatocellular carcinoma
por: Wang, Shi-Jie, et al.
Publicado: (2020)

The roles of toll-like receptor 4, CD33, CD68, CD69, or CD147/EMMPRIN for monocyte activation by the DAMP S100A8/S100A9
por: Möller, Alexander, et al.
Publicado: (2023)

Advances in Mesenchymal Stem Cell-Derived Exosomes as Drug Delivery Vehicles
por: Rao, Dingyu, et al.
Publicado: (2022)

Spongionella Secondary Metabolites, Promising Modulators of Immune Response through CD147 Receptor Modulation
por: Sánchez, Jon Andoni, et al.
Publicado: (2016)

CD147 as a Novel Prognostic Biomarker for Hepatocellular Carcinoma: A Meta-Analysis
por: Peng, Fei, et al.
Publicado: (2017)

CD147 functions as the signaling receptor for extracellular divalent copper in hepatocellular carcinoma cells
por: Ding, Pengfei, et al.
Publicado: (2017)

The inhibition role of miR-22 in hepatocellular carcinoma cell migration and invasion via targeting CD147
por: Luo, Ling-Juan, et al.
Publicado: (2017)

Mini-Review: Can the Metastatic Cascade Be Inhibited by Targeting CD147/EMMPRIN to Prevent Tumor Recurrence?
por: Rahat, Michal A.
Publicado: (2022)

Application of small extracellular vesicles in the diagnosis and prognosis of nasopharyngeal carcinoma
por: Zhang, Jiali, et al.
Publicado: (2023)

CD147 reinforces [Ca(2+)](i) oscillations and promotes oncogenic progression in hepatocellular carcinoma
por: Tang, Juan, et al.
Publicado: (2015)

Doxycycline Inducible Chimeric Antigen Receptor T Cells Targeting CD147 for Hepatocellular Carcinoma Therapy
por: Zhang, Ren-Yu, et al.
Publicado: (2019)

Role of melatonin in the treatment of COVID-19; as an adjuvant through cluster differentiation 147 (CD147)
por: Sehirli, Ahmet Ozer, et al.
Publicado: (2020)

Generation of a High-Affinity Nanobody Against CD147 for Tumor Targeting and Therapeutic Efficacy Through Conjugating Doxorubicin
por: Li, Rifei, et al.
Publicado: (2022)

N-linked glycosylation at Asn152 on CD147 affects protein folding and stability: promoting tumour metastasis in hepatocellular carcinoma
por: Li, Jiang-Hua, et al.
Publicado: (2016)

The Role of CD147 in Pathological Cardiac Hypertrophy Is Regulated by Glycosylation
por: Zhong, Fang-yuan, et al.
Publicado: (2022)

Large-Scale Single-Cell and Bulk Sequencing Analyses Reveal the Prognostic Value and Immune Aspects of CD147 in Pan-Cancer
por: Zhang, Jingwei, et al.
Publicado: (2022)

The Roles of CD147 and/or Cyclophilin A in Kidney Diseases
por: Qu, Xin, et al.
Publicado: (2014)

Role of MMP-2 and CD147 in kidney fibrosis
por: Cheng, Zhengyuan, et al.
Publicado: (2022)

HAb18G/CD147 Regulates Vinculin-Mediated Focal Adhesion and Cytoskeleton Organization in Cultured Human Hepatocellular Carcinoma Cells
por: Liang, Qiang, et al.
Publicado: (2014)

CD93 overexpresses in liver hepatocellular carcinoma and represents a potential immunotherapy target
por: Jiang, Qianwei, et al.
Publicado: (2023)

The Multiple Roles of CD147 in the Development and Progression of Oral Squamous Cell Carcinoma: An Overview
por: Barillari, Giovanni, et al.
Publicado: (2022)

CD147 promotes cell motility via upregulation of p190-B RhoGAP in hepatocellular carcinoma
por: Chen, Ruo, et al.
Publicado: (2016)

Basolateral CD147 induces hepatocyte polarity loss by E‐cadherin ubiquitination and degradation in hepatocellular carcinoma progress
por: Lu, Meng, et al.
Publicado: (2018)

A novel small-molecule compound targeting CD147 inhibits the motility and invasion of hepatocellular carcinoma cells
por: Fu, Zhi-guang, et al.
Publicado: (2016)

Construction and systematic evaluation of a machine learning-based cuproptosis-related lncRNA score signature to predict the response to immunotherapy in hepatocellular carcinoma
por: Lu, Dingyu, et al.
Publicado: (2023)

CD38 marks the exhausted CD8(+) tissue-resident memory T cells in hepatocellular carcinoma
por: Reolo, Marie J. Y., et al.
Publicado: (2023)

CD4+CD25+CD127(low) Regulatory T Cells Play Predominant Anti-Tumor Suppressive Role in Hepatitis B Virus-Associated Hepatocellular Carcinoma
por: Sharma, Shreya, et al.
Publicado: (2015)

EMMPRIN/CD147 plays a detrimental role in clinical and experimental ischemic stroke
por: Patrizz, Anthony, et al.
Publicado: (2020)

An update on the role of complement in hepatocellular carcinoma
por: Xiao, Zhijie, et al.
Publicado: (2022)

Expression patterns of cluster of differentiation 147 impact the prognosis of hepatocellular carcinoma
por: Xu, Yun-Ji, et al.
Publicado: (2023)

Expression of CD38 on Macrophages Predicts Improved Prognosis in Hepatocellular Carcinoma
por: Lam, Jian Hang, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_60hjpdgdssqe8clp76nsg4m7sg